uniQure grants options and RSUs to officer

uniQure N.V. reported that Chief Customer & Strategy Officer Kylie O'Keefe received new equity awards.

Rhea-AI Filing Summary

uniQure N.V. reported that Chief Customer & Strategy Officer Kylie O'Keefe received new equity awards. On March 4, 2026, she was granted stock options for 31,900 shares at an exercise price of $0.00 per share and 19,800 ordinary shares as restricted share units.

The restricted share units vest in three equal annual installments of one-third each, starting on the first anniversary of the grant date, subject to her continued relationship with the company. The stock options vest 25% on the first anniversary and 6.25% quarterly thereafter until fully vested, also contingent on continued service.

Insider Trade Summary

Grant/Award: 51,700 shares

Grant/Award 2 txns

Insider O'Keefe Kylie

Role Chief Customer & Strat Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	31,900	$0.00	$0.00
Grant/Award	Ordinary Shares	19,800	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 31,900 contracts (Direct); Ordinary Shares — 124,800 shares (Direct)

Footnotes (2)

1. F1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.
2. F2. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did uniQure (QURE) report for Kylie O'Keefe?

uniQure reported that Chief Customer & Strategy Officer Kylie O'Keefe received stock options for 31,900 shares and 19,800 ordinary shares as restricted share units, all granted on March 4, 2026 as part of her equity compensation.

Were Kylie O'Keefe’s uniQure (QURE) equity awards open-market purchases or grants?

The Form 4 shows equity awards were grants, not open-market purchases. She acquired 31,900 stock options and 19,800 restricted share units at a price of $0.00 per share under uniQure’s 2014 Share Incentive Plan, as amended and restated.

How do the new uniQure (QURE) restricted share units for Kylie O'Keefe vest?

The 19,800 restricted share units vest in three equal annual installments of one-third each, beginning on the first anniversary of the March 4, 2026 grant date, provided Kylie O'Keefe maintains her relationship with uniQure through each vesting date.

What is the vesting schedule of Kylie O'Keefe’s new uniQure (QURE) stock options?

The 31,900 stock options vest 25% on the first anniversary of the March 4, 2026 grant date, then 6.25% each quarter thereafter until fully vested, conditioned on her continued relationship with uniQure over the vesting period.

What is Kylie O'Keefe’s uniQure (QURE) share ownership after these Form 4 transactions?

After the March 4, 2026 equity awards, Kylie O'Keefe directly holds 31,900 stock options and 124,800 ordinary shares, according to the totals following the reported transactions in the Form 4 insider trading report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Keefe Kylie

(Last) (First) (Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM P7 1105BP

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Customer & Strat Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	03/04/2026		A		19,800(1)	A	$0	124,800	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.04	03/04/2026		A		31,900		(2)	03/04/2036	Ordinary Shares	31,900	$0	31,900	D

Explanation of Responses:

1. Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates.

2. The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates.

	/s/ Christian Klemt, Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.